TechCrunch  Nov 28  Comment 
 MOCAheart wants to make keeping track of your cardiovascular health as easy as pressing a button. The device, which is currently on Kickstarter, was developed by a team led by Naama Stauber and Dr. Daniel Hong, who was a physician at National...
DailyFinance  Nov 22  Comment 
Filed under: Consumer Issues www.owletcare.com Unregulated and expensive wearable devices -- designed to send alerts if a baby stops breathing or his or her heart stops beating -- have only an "illusory" benefit, a British pediatrician...
NPR  Nov 19  Comment 
A new generation of baby monitors lets new parents track their child's heartbeat and other vital signs. But they're not health devices, a pediatrician warns, and could give a false sense of security.
New York Times  Nov 11  Comment 
Doctors treating Ms. Rivers did not notice her deteriorating vital signs for about 15 minutes before she went into cardiac arrest, a report said.
Wall Street Journal  Sep 29  Comment 
Ahead of the Tape: Despite missteps including a $1.1 billion error in guidance, Walgreen's vital signs appear strong. The drugstore operator isn't out of the woods yet, however.
MedPage Today  Sep 9  Comment 
(MedPage Today) -- Just like adults, children and teens in the U.S. consume a great deal of sodium -- about 1,000 mg above the recommended maximum daily intake on average, according to a new CDC "Vital Signs" report.
MarketWatch  Jun 15  Comment 
Fed faces economy with conflicting vital signs
Forbes  Apr 21  Comment 
Microsoft announced today that the acquisition of Nokia's devices and services division will be finalized by Friday 25 April. The $7.2 billion dollar purchase will see the Finnish company hand over their smartphone expertise and portfolio to...
MarketWatch  Apr 14  Comment 
For small-business owners inundated with the tasks of expanding, employee wellness is often far down the list of things to consider. But whether you have five employees or 5,000, paying attention to workers’ general health and helping people...


Headquartered in Totowa, New Jersey, Vital Signs (VITL) is a leading designer, manufacturer, and marketer of airway management products for the anesthesia, respiratory/critical care, and sleep disorder markets. The company sells its products in more than 70 countries globally. The company provides the broadest single-patient use anesthesia and respiratory/critical care product lines in the industry. Beginning in 1997 with the equity interest in Breas Medical AB, the company has expanded its focus to the sleep therapy and personal ventilation markets. It also delivers technology services to FDA regulated companies. The company derives revenues principally from five segments: Anesthesia, Respiratory/Critical Care, Sleep Disorder, Pharmaceutical Technology Services, and Interventional Cardiology/Radiology. The Pharmaceutical Technology Services segment was classified, as of FQ107, as a discontinued operation, with VITL expecting the unit to be sold. However, as of FQ407, the segment has been reclassified to continuing operations since the company received no acceptable offers for sale. The Interventional Cardiology/Radiology business operates primarily as Thomas Medical. It was earlier included in the anesthesia segment, but is now segregated. The company has been operating in the Anesthesia market for 33 years and provides single-patient use anesthesia breathing circuits, face masks, and general anesthesia products. These products comprise air-filled cushion face masks, breathing circuits and temperature monitoring probes, single limb breathing circuits, single use airway devices, and fiberoptic laryngoscope systems. The Respiratory/Critical Care segment provides arterial blood gas syringes and kits, manual resuscitators, and blood pressure cuffs. The company also distributes critical care equipment kits and modules, which are color coded to allow emergency room workers to quickly and accurately determine the proper equipment size to use with pediatric patients. The Sleep Disorder segment offers sleep disorder/personal ventilation products that include continuous positive airway pressure flow generators, humidification systems, sleep disorder home screening devices, life support ventilator, and other ventilators. This segment also provides diagnostic and therapeutic services for sleep disorders. The Pharmaceutical Technology Services segment offers consulting services to medical device, diagnostic, and biotechnology companies, thereby helping the companies to develop and validate systems and processes for their manufacturing, infrastructure, research and development, and laboratory and quality assurance departments. In fiscal 2007 (fiscal year ends September) Anesthesia, Respiratory/Critical Care, Sleep Disorder, Pharmaceutical Technology Services, and Interventional Cardiology/Radiology contributed 36%, 23%, 21%, 6%, and 14% of revenues, respectively.


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki